Wedbush analyst Dan Ives raised his price target for Apple ... persistent inflation and consumer confidence. Apple’s next year’s growth rate is expected to be 13.06% versus the underlying ...

Jan 13 (Reuters) - Abercrombie & Fitch (ANF.N), opens new tab on Monday raised its annual net sales growth target for the current ... it would buy drugmaker Intra-Cellular Therapies for about ...

Satellite services integrated with terrestrial cellular networks are still in their infancy, but the revenue from these is ...

That was the name given to effort that eventually became Apple's (AAPL) first iPhone. Project Purple centered around the creation of two competing phone models. One was based on the iPod nano ...

The upcoming Apple iPhone 17 Pro should borrow these two features from the OnePlus 13 to solve some of its persisting issues.

One of the biggest analyst calls on Tuesday, January 7 th, was for Apple Inc. MoffettNathanson, an investment firm, downgraded the stock to “Sell” from Neutral and lowered his target price for ...

Discounts and sales events have remained a significant sales driver, as consumers emerge from a more than two-year stretch of ...

Wedbush maintained its Outperform rating on Apple (NASDAQ:AAPL) and raised its price target on the stock to ... is heading into a multi-year AI-driven iPhone upgrade cycle, which is still being ...

BofA raised the firm’s price target on Intra-Cellular (ITCI) to $118 from $100 and keeps a Buy rating on the shares after the company announced a favorable Caplyta patent settlement with Sandoz ...